Healthcare

Image

Europe Biotechnology Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Oct 2021
  • Europe
  • 350 Pages
  • No of Tables: 244
  • No of Figures: 45

Europe Biotechnology Market, By Product Type (Instruments, Reagents And Services & Software), Technology (Nano Biotechnology, PCR Technology, DNA Sequencing, Chromatography, Tissue Engineering And Regeneration, Cell-Based Assays, Fermentation And Others), Application (Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics And Bio-agriculture), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes And Others), Distribution Channel (Direct Tender, Third Party Distributors, And Others), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast To 2028.

Europe Biotechnology Market Market Analysis and Insights: Europe Biotechnology Market

The biotechnology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 27.9% in the forecast period of 2021 to 2028 and is expected to reach USD 2,691,409.16 million by 2028. Rising prevalence of chronic diseases demands the advanced biotechnology products and instruments which is acts as driver for the biotechnology market growth.

Biotechnology is a technology that utilizes biological systems, living organisms, or parts of this to develop or create different products. Brewing and baking bread are instances of processes that fall within the concept of biotechnology (use of yeast (living organism) to produce the desired product). Such traditional processes usually utilize the living organisms in their natural form (or further developed by breeding), while the more modern form of biotechnology will generally involve a more advanced modification of the biological system or organism. Today, biotechnology covers many different disciplines (for instances genetics, biochemistry, and molecular biology, among others). New technologies and products are developed every year within the areas of medicine (development of new medicines and therapies), agriculture (development of genetically modified plants, biofuels, biological treatment), or industrial biotechnology (production of chemicals, paper, textiles, and food).

The biotechnology market is growing due to the increased incidence of chronic diseases and the rise in technological advancement. Moreover, an increasing number of product approval is another factor that accelerating the biotechnology market growth. Lack of skilled professionals is expected to restraint the global biotechnology market growth.

The biotechnology market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the biotechnology market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Biotechnology Market Biotechnology Market Scope and Market Size

The biotechnology market is segmented on the based on the product type, technology, application, end user and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the biotechnology market is segmented into instruments, reagents and services & software. In 2021, the instruments segment is expected to dominate the biotechnology market due to the availability of a diverse range of innovative solutions.
  • On the basis of technology, the biotechnology market is segmented into nanobiotechnology, PCR technology, DNA sequencing, chromatography, tissue engineering and regeneration, cell-based assays, fermentation, and others. In 2021, the nanobiotechnology segment is expected to dominate the biotechnology market due to its broad range of applications.
  • On the basis of application, the biotechnology market is segmented into bio-pharmacy, bio-industrial, bio-services, bioinformatics and bio-agriculture. In 2021, bio-pharmacy segment is expected to dominate the biotechnology market due to the rising number of research and development activities.
  • On the basis of end user, the biotechnology market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes and others. In 2021, the pharmaceutical & biotechnology companies segment is expected to dominate the biotechnology market due to increasing initiative activities by various healthcare organizations and government bodies to encourage research endeavors.
  • On the basis of distribution channel, the biotechnology market is segmented into direct tender, third party distributors, and others. In 2021, the direct tender segment is expected to dominate the biotechnology market due to the rising demand for biotechnology instruments.

Biotechnology Market Country Level Analysis

The biotechnology market is analyzed and market size information is provided by the country, product type, technology, application, end user and distribution channel as referenced above.

The countries covered in the biotechnology market report are the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Ireland, and Rest of Europe.

Germany is dominating the European market owing to increasing research and development for the biotechnology products and software.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Biotechnology, is Boosting the Market Growth

The biotechnology market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Biotechnology Market Share Analysis

Biotechnology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to biotechnology market.

The major companies which are dealing in the biotechnology are Trinity Biotech, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc.,   Illumina, Inc.,  Pacific Biosciences of California, Inc. and Biogen among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the biotechnology market.

For instance,

  • In February 2021, Thermo Fisher Scientific Inc. has announced it has completed its previously announced acquisition of Mesa Biotech, Inc. This acquisition anticipated to strengthen company’s leadership in biotechnology market.
  • In March 2021, Charles River Laboratories has announced that it has acquired Retrogenix Limited, an early-stage contract research organization (CRO) providing specialized bioanalytical services utilizing its proprietary cell microarray technology. This acquisition anticipated strengthen company’s bioanalytical business sector.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the biotechnology market which also provides the benefit for organization’s profit growth.


SKU-

TABLE 1 EUROPE CANCER INCIDENCE IN BOTH THE GENDERS (2018)

TABLE 2 EUROPE CANCER INCIDENCE IN MEN (2018)

TABLE 3 EUROPE CANCER INCIDENCE IN WOMEN (2018)

TABLE 4 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 5 EUROPE INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 9 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 11 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 13 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 15 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 17 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 21 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 23 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 EUROPE ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 36 EUROPE DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 40 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 41 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 43 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 44 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 45 EUROPE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 46 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 47 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 48 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 49 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 GERMANY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 53 GERMANY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 54 GERMANY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 55 GERMANY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 56 GERMANY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 57 GERMANY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 58 GERMANY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 59 GERMANY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 60 GERMANY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 61 GERMANY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 62 GERMANY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 63 GERMANY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 FRANCE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 65 FRANCE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 66 FRANCE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 67 FRANCE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 68 FRANCE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 69 FRANCE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 70 FRANCE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 71 FRANCE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 72 FRANCE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 73 FRANCE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 74 FRANCE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 75 FRANCE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 76 U.K. BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 77 U.K. BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 78 U.K. FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 79 U.K. TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 80 U.K. PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 81 U.K. NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 82 U.K. CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 83 U.K. DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 84 U.K. CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 85 U.K. BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 U.K. BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 U.K. BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 ITALY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 89 ITALY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 90 ITALY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 91 ITALY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 92 ITALY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 93 ITALY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 94 ITALY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 95 ITALY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 96 ITALY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 97 ITALY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 98 ITALY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 ITALY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 SPAIN BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 101 SPAIN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 102 SPAIN FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 103 SPAIN TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 104 SPAIN PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 105 SPAIN NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 106 SPAIN CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 107 SPAIN DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 108 SPAIN CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 109 SPAIN BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 SPAIN BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 111 SPAIN BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 112 BELGIUM BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 113 BELGIUM BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 BELGIUM FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 115 BELGIUM TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 116 BELGIUM PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 117 BELGIUM NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 118 BELGIUM CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 119 BELGIUM DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 120 BELGIUM CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 121 BELGIUM BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 122 BELGIUM BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 123 BELGIUM BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 124 NETHERLANDS BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 125 NETHERLANDS BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 126 NETHERLANDS FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 127 NETHERLANDS TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 128 NETHERLANDS PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 129 NETHERLANDS NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 130 NETHERLANDS CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 131 NETHERLANDS DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 132 NETHERLANDS CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 133 NETHERLANDS BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 134 NETHERLANDS BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 135 NETHERLANDS BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 136 RUSSIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 137 RUSSIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 138 RUSSIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 139 RUSSIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 140 RUSSIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 141 RUSSIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 142 RUSSIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 143 RUSSIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 144 RUSSIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 145 RUSSIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 RUSSIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 147 RUSSIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 148 SWITZERLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 149 SWITZERLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 150 SWITZERLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 151 SWITZERLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 152 SWITZERLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 153 SWITZERLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 154 SWITZERLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 155 SWITZERLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 156 SWITZERLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 157 SWITZERLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 158 SWITZERLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 159 SWITZERLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 160 TURKEY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 161 TURKEY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 162 TURKEY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 163 TURKEY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 164 TURKEY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 165 TURKEY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 166 TURKEY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 167 TURKEY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 168 TURKEY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 169 TURKEY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 170 TURKEY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 171 TURKEY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 172 AUSTRIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 173 AUSTRIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 174 AUSTRIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 175 AUSTRIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 176 AUSTRIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 177 AUSTRIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 178 AUSTRIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 179 AUSTRIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 180 AUSTRIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 181 AUSTRIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 182 AUSTRIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 183 AUSTRIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 184 NORWAY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 185 NORWAY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 186 NORWAY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 187 NORWAY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 188 NORWAY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 189 NORWAY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 190 NORWAY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 191 NORWAY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 192 NORWAY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 193 NORWAY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 194 NORWAY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 195 NORWAY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 196 HUNGARY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 197 HUNGARY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 198 HUNGARY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 199 HUNGARY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 200 HUNGARY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 201 HUNGARY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 202 HUNGARY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 203 HUNGARY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 204 HUNGARY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 205 HUNGARY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 206 HUNGARY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 207 HUNGARY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 208 LITHUANIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 209 LITHUANIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 210 LITHUANIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 211 LITHUANIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 212 LITHUANIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 213 LITHUANIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 214 LITHUANIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 215 LITHUANIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 216 LITHUANIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 217 LITHUANIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 218 LITHUANIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 219 LITHUANIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 220 IRELAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 221 IRELAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 222 IRELAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 223 IRELAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 224 IRELAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 225 IRELAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 226 IRELAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 227 IRELAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 228 IRELAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 229 IRELAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 230 IRELAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 231 IRELAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 232 POLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 233 POLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 234 POLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 235 POLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 236 POLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 237 POLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 238 POLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 239 POLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 240 POLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 241 POLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 242 POLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 243 POLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 244 REST OF EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials